Barclays PLC Sells 211,901 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Barclays PLC reduced its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 62.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 129,133 shares of the company’s stock after selling 211,901 shares during the period. Barclays PLC owned 0.10% of Surgery Partners worth $4,164,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of SGRY. KBC Group NV grew its holdings in Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares during the period. Quarry LP boosted its position in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after purchasing an additional 1,760 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. grew its position in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after buying an additional 3,379 shares during the period. Creative Planning bought a new position in Surgery Partners in the 3rd quarter worth $258,000. Finally, Versor Investments LP bought a new position in shares of Surgery Partners in the third quarter worth about $271,000.

Surgery Partners Trading Up 8.2 %

Shares of SGRY stock opened at $21.22 on Monday. The stock’s fifty day moving average is $25.99 and its two-hundred day moving average is $27.77. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a market capitalization of $2.70 billion, a P/E ratio of -44.21, a PEG ratio of 17.40 and a beta of 2.58. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $35.29.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company’s revenue was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.15 earnings per share. Research analysts expect that Surgery Partners, Inc. will post 0.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SGRY has been the subject of several research analyst reports. Bank of America began coverage on Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price for the company. Benchmark reaffirmed a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a research note on Monday, August 26th. Cantor Fitzgerald reissued an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research note on Friday, October 4th. UBS Group started coverage on Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 price target for the company. Finally, JPMorgan Chase & Co. decreased their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $36.56.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.